Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1996;74(1):19–24.

Rapid and simple hepatitis assays: encouraging results from a blood donor population in Zimbabwe.

D Mvere 1, N T Constantine 1, E Katsawde 1, O Tobaiwa 1, S Dambire 1, P Corcoran 1
PMCID: PMC2486854  PMID: 8653812

Abstract

A rapid assay to detect antibodies to hepatitis C virus (HCV) in serum and two rapid/simple assays to detect hepatitis B surface antigen (HBsAg) in whole blood/serum were evaluated for their accuracy and suitability at the National Blood Transfusion Service, Harare, Zimbabwe. For this purpose, a total of 206 sera (196 routinely collected and 10 frozen) were tested using the HCV-SPOT (Genelabs Diagnostics), the SimpliRED HBsAg test (AGEN), and the Dipstick-HBsAg (PATH/Immuno-Chemical Laboratories). The results were compared with those obtained using a routine HBsAg enzyme immunoassay (EIA) (Auszyme, Abbott) and an HCV IgG second-generation EIA (Abbott). An HCV IgM test (Abbott) was used for samples that produced discordant results, and all HCV-reactive samples were confirmed using the INNO-LIA HCV Ab III synthetic peptide assay (Innogenetics). Overall, the concordance between the HCV-SPOT and the HCV EIA was 97.6% (201/206). For the 193 sera that were true HCV negatives, the number of false positives was six with the HCV-SPOT test, while the HCV EIA produced three (specificity = 97.0% and 98.5%, resp.). Of these false positives, two were so in both tests. None of the false positives contained IgM antibodies to HCV, and there were no false negatives in the two HCV tests. The concordance between the two rapid HBsAg tests and the HBsAg EIA was 99.5% (205/206). All the rapid/simple tests were easy to perform and interpret, required no (or minimal) laboratory equipment, and could be taught easily to local laboratory personnel. The cost of these tests is equivalent to or less than that of routine EIA methods.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behets F., Bishagara K., Disasi A., Likin S., Ryder R. W., Brown C., Quinn T. C. Diagnosis of HIV infection with instrument-free assays as an alternative to the ELISA and western blot testing strategy: an evaluation in Central Africa. J Acquir Immune Defic Syndr. 1992;5(9):878–882. [PubMed] [Google Scholar]
  2. Bredberg-Rådén U., Kiango J., Mhalu F., Biberfeld G. Evaluation of commercial enzyme immunoassays for anti-HIV-1 using East African sera. AIDS. 1988 Aug;2(4):281–285. doi: 10.1097/00002030-198808000-00007. [DOI] [PubMed] [Google Scholar]
  3. Callahan J. D., Constantine N. T., Kataaha P., Zhang X., Hyams K. C., Bansal J. Second generation hepatitis C virus assays: performance when testing African sera. J Med Virol. 1993 Sep;41(1):35–38. doi: 10.1002/jmv.1890410108. [DOI] [PubMed] [Google Scholar]
  4. Constantine N. T., Holm-Hansen C., Skaug N., Vasilescu F. Successful use of two rapid HCV assays in a high prevalence Romanian population. J Clin Lab Anal. 1994;8(5):332–334. doi: 10.1002/jcla.1860080513. [DOI] [PubMed] [Google Scholar]
  5. Constantine N. T., Zhang X., Li L., Smialek J. E. Detection of antibodies to hepatitis C virus in urine. Lancet. 1992 Jun 27;339(8809):1607–1608. doi: 10.1016/0140-6736(92)91870-e. [DOI] [PubMed] [Google Scholar]
  6. Coursaget P., Yvonnet B., Bourdil C., Mevelec M. N., Adamowicz P., Barrès J. L., Chotard J., N'Doye R., Diop Mar I., Chiron J. P. HBsAG positive reactivity in man not due to hepatitis B virus. Lancet. 1987 Dec 12;2(8572):1354–1358. doi: 10.1016/s0140-6736(87)91255-4. [DOI] [PubMed] [Google Scholar]
  7. Lai M. E., Farci P., Figus A., Balestrieri A., Arnone M., Vyas G. N. Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. Blood. 1989 Jan;73(1):17–19. [PubMed] [Google Scholar]
  8. Ratnam S., Stead F., Head C. B. False-positive results with third-generation monoclonal hepatitis B surface antigen enzyme immunoassay. J Clin Microbiol. 1989 Sep;27(9):2102–2104. doi: 10.1128/jcm.27.9.2102-2104.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Schüpbach J., Tanner M. Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania. Acta Trop. 1986 Sep;43(3):195–206. [PubMed] [Google Scholar]
  10. Tamashiro H., Constantine N. T. Serological diagnosis of HIV infection using oral fluid samples. Bull World Health Organ. 1994;72(1):135–143. [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES